Focus on α4β2* and α6β2* nAChRs for Parkinson’s Disease Therapeutics
Read more from SRI
-
SRI is building an AI assistant for scientific research
A collaborative project that crosses multiple SRI labs and divisions is refining an application designed to take the drudgery out of scientific literature reviews.
-
SRI receives FDA clearance to initiate a clinical trial of high-dose naloxone
Researchers say the new formulation could reduce overdose fatalities caused by fentanyl and other synthetic opioids.
-
Helping pre-teens get the sleep they need
The American Academy of Sleep Medicine highlights SRI research focused on the relationship between parental engagement and pre-teen sleep.